Michigan hospitals are systematically exploiting a program for low-income patients, according to a new report.

The 340B Drug Pricing Program was meant to help low-income patients, writes Rick Dowlearn, but it’s being used by hospitals ...

While more than 2,900 U.S. hospitals hold tax-exempt status as nonprofits, critics argue they have undergone a “mission drift ...

As the January 1 implementation date approaches, here is a quick guide to the controversial new rebate model for the 340B Drug Pricing Program and the legal battle to stop it.

A Colorado district court judge denied drug manufacturer AstraZeneca’s request for an injunction to block enforcement of a recent law barring drug manufacturers from imposing restrictions on covered ...

As we look ahead to 2026, the operational demands on 340B programs are increasing across every dimension. Between the implementation of the 340B ...

Chicago-based AbbVie Inc., whose products include the wrinkle-remover Botox and the arthritis drug Humira, sued the state earlier this year in the U.S. District Court of South Dakota.

From the denials to critical updates on 340B and prior authorization, here is a look back at the trends and tactics that defined the revenue cycle in 2025.

The 2025 pharmaceutical pipeline is expanding with generics, biosimilars, and new therapies, despite delays from patent ...

(TNND) — Pharmacy professors offered tips to keep drug costs in check as a third of Americans report leaving prescriptions ...